Preprint Review Version 1 This version is not peer-reviewed

Molecular Targets for the Diagnosis and Treatment of Pancreatic Cancer

Version 1 : Received: 25 July 2024 / Approved: 26 July 2024 / Online: 26 July 2024 (12:58:56 CEST)

How to cite: Pergolizzi, R. G.; Brower, S. Molecular Targets for the Diagnosis and Treatment of Pancreatic Cancer. Preprints 2024, 2024072126. https://doi.org/10.20944/preprints202407.2126.v1 Pergolizzi, R. G.; Brower, S. Molecular Targets for the Diagnosis and Treatment of Pancreatic Cancer. Preprints 2024, 2024072126. https://doi.org/10.20944/preprints202407.2126.v1

Abstract

Pancreatic cancer is one of the most aggressive and lethal forms of cancer, with a five-year survival rate of less than 10%. Despite advances in treatment modalities, the prognosis for pancreatic cancer patients remains poor, highlighting the urgent need for innovative approaches for early diagnosis and targeted therapies. In recent years, there has been significant progress in understanding the molecular mechanisms underlying pancreatic cancer development and progression. This paper reviews the current knowledge of molecular targets for the diagnosis and treatment of pancreatic cancer.

Keywords

PC (pancreatic cancer]); driver mutations; miRNA

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.